SearchDictionaryMobileLogin

S E Humphries Selected Research

Interleukin-6 (Interleukin 6)

08/2006The interleukin-6 gene -174G>C and -572G>C promoter polymorphisms are related to cerebral aneurysms.
04/2005Interaction between the C-260T polymorphism of the CD14 gene and the plasma IL-6 concentration on the risk of myocardial infarction: the HIFMECH study.
01/2003Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women.
12/2001The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men.
05/2001Interleukin-6 (IL-6) and the prognosis of abdominal aortic aneurysms.
01/2001A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women.
12/2000Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis.
11/2000Effects of sample handling on the stability of interleukin 6, tumour necrosis factor-alpha and leptin.
10/2000Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6.
02/2000Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

Articles by Research Topic

Disease

7Myocardial Infarction
10/2007 - 01/2001
7Coronary Disease (Coronary Heart Disease)
12/2005 - 02/2000
3Cardiovascular Diseases (Cardiovascular Disease)
07/2007 - 11/2005
3Coronary Artery Disease (Coronary Atherosclerosis)
08/2001 - 10/2000
2Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
07/2008 - 11/2003
2Intracranial Aneurysm (Cerebral Aneurysm)
08/2006 - 08/2005
2Bone Resorption
01/2003 - 01/2001
2Inflammation
10/2000 - 02/2000
2Obesity
03/2000 - 02/2000
1Hypertriglyceridemia
10/2008
1Disease Susceptibility (Diathesis)
03/2007
1Diabetes Mellitus
11/2006
1Syndrome
10/2006
1Insulin Resistance
10/2006
1Myocardial Ischemia (Ischemic Heart Diseases)
11/2001
1Abdominal Aortic Aneurysm
05/2001
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
01/2001
1Atherosclerosis (Atheroma)
12/2000
1Necrosis
11/2000
1Heart Diseases (Heart Disease)
03/2000

Drug/Important Bio-Agent (IBA)

10Interleukin-6 (Interleukin 6)IBA
08/2006 - 02/2000
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
10/2008 - 03/2000
2LDL Receptors (LDL Receptor)IBA
07/2008 - 11/2003
2Plasminogen Activators (Plasminogen Activator)IBA
10/2007 - 11/2003
2AdiponectinIBA
07/2007 - 10/2006
21-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA
11/2006 - 06/2003
2Apolipoprotein E4IBA
11/2005 - 07/2001
2SmokeIBA
11/2005 - 07/2001
2Factor VII (Proconvertin)IBA
10/2003 - 10/2000
1Plasminogen Activator Inhibitor 1IBA
10/2007
1Interleukin-18 (Interleukin 18)IBA
03/2007
1Prothrombin (Factor II)IBA
12/2005
1Heme Oxygenase-1IBA
08/2005
1ThrombomodulinIBA
11/2004
1ProinsulinIBA
11/2003
1Insulin (Novolin)FDA Link
11/2003
1C-Reactive ProteinIBA
01/2003
1AntigensIBA
05/2002
1Carboxypeptidase U (TAFI)IBA
05/2002
1Nitrogen OxidesIBA
11/2001
1Lipoproteins (Lipoprotein)IBA
08/2001
1Thrombopoietin (c-mpl Ligand)IBA
02/2001
1Losartan (Cozaar)FDA Link
01/2001
1Fibrinogen (Factor I)IBA
01/2001
1Lipoprotein(a)IBA
01/2001
1LeptinIBA
11/2000
1Fibrinopeptide AIBA
10/2000
1Factor XIIa (Coagulation Factor XIIa)IBA
10/2000
1Apolipoprotein B-100 (Apo B 100)IBA
03/2000
1AsparagineIBA
03/2000
1Aspartic Acid (Aspartate)FDA Link
03/2000